Gal Gur PhD., Vice President, Business Development

Dr. Gal Gur has over 15 years of experience in biotech companies, spanning roles in both R&D and Business Development. She served as the Director of Business Development at T3, the Technion Technology Transfer. There, she managed a wide range of biotech, biomed, and pharma licensing projects. Her responsibilities also encompassed the establishment of spinoffs, commercialization activities, and the due diligence and development of companies and technologies.

Before her tenure at T3, Dr. Gur held leadership roles in the R&D departments of major global companies, including Sigma-Aldrich and subsequently Merck KGaA. At Merck KGaA, she led the Innovative Technologies department, focusing on scouting and evaluating Life Science technologies, and establishing collaborations.

Gal earned her PhD from Tel Aviv University and completed her postdoctoral fellowship at the Weizmann Institute.